Features | Partner Sites | Information | LinkXpress
Sign In

Microsensor Measures Intraocular Pressure in Glaucoma

By HospiMedica International staff writers
Posted on 18 Aug 2014
Image: The Pro-IOP eye pressure measurement system implant (Photo courtesy of Implandata Ophthalmic Products).
Image: The Pro-IOP eye pressure measurement system implant (Photo courtesy of Implandata Ophthalmic Products).
An implantable microsensor for wireless intraocular pressure (IOP) measurement allows close monitoring of patients’ disease status and glaucoma therapy success.

The Pro-IOP eye pressure measurement system consists of an implantable microsensor, an external hand held device that telemetrically transfers energy to the microsensor, and a cellular GSM module, which connects with the hand held device to transfer measurement data to a database that can be accessed by clinicians to review the disease status of the patient. Optionally, the patient can also have limited access to the data via an App, in order to review data history or communicate with the ophthalmologist.

The Pro-IOP delivers direct and real IOP, as expressed in mm Hg, which facilitates measurement without disrupting the patient’s lifestyle and without compromising the patient’s behavior. At the same time, the system discloses to clinicians real time, crucial information regarding patient specific pressure fluctuation and variability, shows if the chosen therapeutic measures work, and reports patient therapy adherence. The system is designed for easy patient use and can also be integrated into telemedicine systems for remote patient management.

The Pro-IOP eye pressure measurement system is a product of Implandata Ophthalmic Products (Hannover, Germany). The company has recently reported the successful implantation of the first patient within the ARGOS-02 clinical study, held at Augenklinik Bellevue (Kiel, Germany). In the ARGOS-02 clinical study, six eye centers in Germany are currently recruiting primary open angle glaucoma patients undergoing cataract extraction.

“So far the first results of this innovative product are very compelling,” said Prof. Detlef Uthoff, MD, medical director of Augenklinik Bellevue. “Up to date, early diagnosis and therapeutic management of the disease have been rather dissatisfying for eye doctors. But this innovation allows us for the first time to personalize and control therapy according to the specific needs of the glaucoma patient.”

Related Links:

Implandata Ophthalmic Products
Augenklinik Bellevue

Cincinnati Sub-Zero
Asian Healthcare Show


Surgical Techniques

view channel

Primary Surgery Beneficial in Advanced Throat Cancers

Patients with cancer of the mid- and lower throat may have higher survival rates if their initial treatment includes surgery, according to a new study. Researchers at Koo Foundation Sun Yat-Sen Cancer Center (KFSYSCC; Taipei City, Taiwan) conducted an observational study, identifying all newly-diagnosed oropharyngeal... Read more

Women's Health

view channel

Pregnancy Complications Raise Heart Disease Risk

A new study suggests a high correlation between women who experienced complications during pregnancy and those facing death from heart disease later in life. Researchers at the Public Health Institute (PHI; Oakland, CA, USA; Berkeley, CA) conducted a study involving 14,062 women, examining pregnancy events over five... Read more

Patient Care

view channel
Image: The NIFTY cup (Photo courtesy of PATH).

NIFTY Cup Aids Infants Who Cannot Breastfeed

A novel cup has been designed to facilitate feeding and prevent starvation in infants in developing countries who are unable to breastfeed. The Neonatal Intuitive Feeding TechnologY (NIFTY) cup, developed... Read more

Hospital News

view channel

Universal Health Services to Acquire Foundations Recovery Network

Hospital operator Universal Health Services (UHS; King of Prussia, PA, USA) has entered an agreement to buy addiction treatment provider Foundations Recovery Network (FRN; Brentwood, TN, USA) for USD 350 million. Founded in 1995, FRN is a leader in addiction treatment and focused on treating adults with addiction and... Read more


view channel

GE Healthcare to Support Emerging Market Health

GE Healthcare (GE; Little Chalfont, United Kingdom) has announced the creation of a new business unit that will develop solutions to improve emerging market health outcomes. The new Sustainable Healthcare Solutions (SHS) business will focus on the expansion of the company’s affordable healthcare portfolio, including... Read more


08 Oct 2015 - 10 Oct 2015
08 Oct 2015 - 10 Oct 2015
08 Oct 2015 - 10 Oct 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.